Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-01-06 5:25 pm Purchase | 13G | SAVARA INC SVRA | EcoR1 Capital LLC | 4,473,204 8.3% | 4,473,204 (New Position) | View |
2020-01-06 5:11 pm Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | EcoR1 Capital LLC | 6,896,551 7.8% | 6,896,551 (New Position) | View |
2020-01-03 4:46 pm Purchase | 13G | REGULUS THERAPEUTICS INC RGLS | EcoR1 Capital LLC | 2,322,644 9.99% | 2,322,644 (New Position) | View |
2019-12-27 5:03 pm Purchase | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | EcoR1 Capital LLC | 3,915,880 8.1% | 3,915,880 (New Position) | View |
2019-12-27 5:02 pm Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | EcoR1 Capital LLC | 1,811,000 6.6% | 1,811,000 (New Position) | View |
2019-12-23 5:01 pm Purchase | 13G | ASSEMBLY BIOSCIENCES INC ASMB | EcoR1 Capital LLC | 2,388,268 7.7% | 1,885,768 (+375.28%) | View |
2019-12-17 4:35 pm Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | EcoR1 Capital LLC | 1,200,000 7.2% | 1,200,000 (New Position) | View |
2019-12-13 5:30 pm Unchanged | 13D | PROTHENA CORP PLC SHS PRTA | EcoR1 Capital LLC | 9,426,640 23.6% | 0 (Unchanged) | View |
2019-11-18 4:08 pm Purchase | 13G | ANAPTYSBIO INC ANAB | EcoR1 Capital LLC | 1,720,500 6.3% | 1,720,500 (New Position) | View |
2019-11-14 4:45 pm Purchase | 13G | PIERIS PHARMACEUTICALS INC PIRS | EcoR1 Capital LLC | 5,070,424 8.8% | 5,070,424 (New Position) | View |
2019-10-23 4:08 pm Purchase | 13G | INNATE PHARMA S A SPONSORED AD IPHA | EcoR1 Capital LLC | 6,623,114 8.4% | 6,623,114 (New Position) | View |
2019-10-15 5:09 pm Purchase | 13G | ZAFGEN INC ZFGN | EcoR1 Capital LLC | 3,141,323 8.4% | 3,141,323 (New Position) | View |
2019-10-07 4:02 pm Purchase | 13G | EXICURE INC XCUR | EcoR1 Capital LLC | 5,945,225 7.8% | 5,945,225 (New Position) | View |
2019-08-26 3:53 pm Purchase | 13D | PROTHENA CORP PLC SHS PRTA | EcoR1 Capital LLC | 9,426,640 23.6% | 9,426,640 (New Position) | View |
2019-08-02 4:03 pm Purchase | 13G | SOLID BIOSCIENCES INC SLDB | EcoR1 Capital LLC | 3,102,238 6.7% | 3,102,238 (New Position) | View |
2019-07-09 10:18 am Purchase | 13G | MORPHIC HLDG INC MORF | EcoR1 Capital LLC | 2,239,704 7.6% | 2,239,704 (New Position) | View |
2019-06-28 4:17 pm Purchase | 13G | PREVAIL THERAPEUTICS INC PRVL | EcoR1 Capital LLC | 2,392,556 7% | 2,392,556 (New Position) | View |
2019-06-28 4:05 pm Purchase | 13G | ATRECA INC BCEL | EcoR1 Capital LLC | 1,486,979 7.1% | 1,486,979 (New Position) | View |
2019-05-10 4:34 pm Sale | 13G | ASSEMBLY BIOSCIENCES INC ASMB | EcoR1 Capital LLC | 502,500 1.9% | -1,902,353 (-79.10%) | View |